Crystal NAX (Crystal Nucleic Acid Excellence) is a wholly owned business entity of Crystal Group. We specialize in providing end-to-end solutions for RNA therapeutics and non-viral delivery. We integrate RNA and DNA synthesis and production, Lipid Nanoaprticles (LNPs) formulation, and comprehensive analytical characterization to deliver the best quality products and services.

Core capabilities :

- RNA Design & Production: mRNA, saRNA, circRNA, sgRNA and other therapeutic RNA modalities.

- LNP Formulation & Delivery Development: Custom xLNP and tLNP formulation, high throughput formulation screening and optimization.

- Analytical Characterization: Routine tests and extended characterization of RNA and LNPs.

- CMC for IND/IIT packages: Customized process and analytical development package to ensure smooth IND/IIT enabling production and good quality control for various modalities.

- Catalog Products & Reagents: Top quality off-the-shelf catalog products and reagents ready for R&D use.

At Crystal NAX, we partner with academic researchers, biotech innovators and global pharmaceutical leaders to transform nucleic acid science into therapies that shape the future of medicine.